"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections" stated...
In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid...
SUNNYVALE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a global leader in cellular and cell-derived therapeutics for the...
ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
Tria helps federal health agencies achieve their critical missions by navigating complex tradeoffs between cost, quality, and access to care...
DELRAY BEACH, FL / ACCESS Newswire / May 6, 2026 / Better Addiction Care, a leading informational resource and web...
Bombshell lawsuits, a European safety bombshell, and a rogue Medicare program converge in the most dangerous moment in American cannabinoid...
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the...
"You cannot responsibly introduce products into a Medicare population when their chemistry is not fully defined and their safety cannot...
ATLANTA, GA / ACCESS Newswire / May 4, 2026 / Alliant Health Solutions (AHS) announced it has been awarded new...
Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears...
Oral argument heard Friday, May 1, 2026 in Smart Approaches to Marijuana v. Kennedy — with Ilya Shapiro arguing for plaintiffs...
Irvine, California, May 01, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with...
The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale. NEW YORK CITY,...
"Without clinical evidence, without public notice, and without congressional authorization, the federal government inserted psychoactive consumer products into Medicare -...
For an accessible version of this Press Release, please visit www.tevapharm.com Q1 2026 revenues of ~$4.0 billion increased by 2%...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales (recorded by Sanofi) increased...
SALT LAKE CITY, April 28, 2026 /PRNewswire/ -- HealthTree Foundation was included in a group of 20 out of 700 applications...
DALLAS, April 27, 2026 /PRNewswire/ -- IntraCare, a leading primary care management organization focused on value-based care, today announced a...
DALLAS, April 27, 2026 /PRNewswire/ -- IntraCare, a leading primary care management organization focused on value-based care, today announced a...